Butterfly Network (NYSE: $BFLY) is working to make its pocket-sized, smartphone-directed ultrasound as “ubiquitous as the stethoscope” – hoping to give docs and nurses at the point-of-care the ability to easily perform any type of scan and instantly see the results. Dr. John Martin, Butterfly’s Chief Medical Officer, talks us through the technology behind the $2,400 hand-held device and how the company is working with healthcare orgs to integrate ultrasound into their workflows — completely shifting the paradigm for where-and-when scans are performed and able to be utilized.
What does this paradigm shift toward on-demand, point-of-care ultrasound really mean for the practice of medicine? Is this over-medicalization and unnecessary, or the key to higher-quality care? And, what about the risk involved in taking ultrasound out of the specialized-and-certified arena of the radiology department and democratizing it for front-line practitioners?
John lets us ask all the tough questions, talks through what’s being learned as Butterfly scales-up and builds its body of use cases, and gives us some insight on how the business itself is doing after going public via SPAC last year. Fun fact on the diversity of those use cases: Beyond human healthcare and the very important work of helping improve maternal and fetal health in Africa via a $5 million dollar grant from the Bill & Melinda Gates Foundation, Butterfly is also being rolled-out across 200 Petco care centers to help veterinarians use point-of-care scans to treat our pets.